Detalles de la búsqueda
1.
Rapid Rebound of a Preexisting CXCR4-tropic Human Immunodeficiency Virus Variant After Allogeneic Transplantation With CCR5 Δ32 Homozygous Stem Cells.
Clin Infect Dis
; 68(4): 684-687, 2019 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30020413
2.
HIV-1 persistent viremia is frequently followed by episodes of low-level viremia.
Med Microbiol Immunol
; 206(3): 203-215, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-28220254
3.
Cell-to-cell spread inhibiting antibodies constitute a correlate of protection against herpes simplex virus type 1 reactivations: A retrospective study.
Front Immunol
; 14: 1143870, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37006290
4.
Role of BK polyomavirus (BKV) and Torque teno virus (TTV) in liver transplant recipients with renal impairment.
J Med Microbiol
; 67(10): 1496-1508, 2018 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-30136921
5.
A Therapeutic Antiviral Antibody Inhibits the Anterograde Directed Neuron-to-Cell Spread of Herpes Simplex Virus and Protects against Ocular Disease.
Front Microbiol
; 8: 2115, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-29163407
6.
Reduced Frequencies and Activation of Regulatory T Cells After the Treatment of HIV-1-Infected Individuals with the CCR5 Antagonist Maraviroc Are Associated with a Reduction in Viral Loads Rather Than a Direct Effect of the Drug on Regulatory T Cells.
Viral Immunol
; 29(3): 192-6, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-27035639
7.
Prevention of herpes simplex virus induced stromal keratitis by a glycoprotein B-specific monoclonal antibody.
PLoS One
; 10(1): e0116800, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25587898
Resultados
1 -
7
de 7
1
Próxima >
>>